Mike McClung — ASN Events

Mike McClung — ASN Events

Michael McClung

Oregon Osteoporosis Center, OR, United States

This delegate is presenting an abstract at this event.

Presentations this author is a contributor to:

Subject characteristics and changes in bone mineral density after transitioning from denosumab to alendronate in the denosumab adherence preference satisfaction (DAPS) study (#74)

Session 7 – Bone Health in the Disadvantaged